by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersGreat India Overseas Pvt. Ltd. dba Silkrute

All Warning Letters

Great India Overseas Pvt. Ltd. dba Silkrute

Warning LetterOpen

Great India Overseas Pvt. Ltd. dba Silkrute, #72 Sahni Complex, Model Town Yamunanagar 135001 Haryana IndiaIssued Jun 17, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateJun 17, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Great India Overseas Pvt. Ltd. dba Silkrute
Location: Great India Overseas Pvt. Ltd. dba Silkrute, #72 Sahni Complex, Model Town Yamunanagar 135001 Haryana India
FEI Number: N/A
Country: India
Issue Date: June 17, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Unapproved New Drugs

Great India Overseas Pvt. Ltd. dba Silkrute FDA Warning Letter, June 17, 2026